Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

21:17 EST 19th December 2014 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 8,400+

Wednesday 17th December 2014

Pieris Pharmaceuticals, Inc. Goes Public, Raises $12.2 Million

FREISING, GERMANY--(Marketwired - December 18, 2014) - Pieris Pharmaceuticals, Inc. (OTC PINK: PIRS) (formerly Marika, Inc.), a Nevada corporation, announced today its successful completion of a share exchange transaction with Pieris AG, a German stock corporation pursuant to which Pieris AG became a wholly-owned subsidiary of the Company. The combined entity is named Pieris Pharmaceuticals, Inc....

Daxor Corporation Appoints Michael Feldschuh as Executive Vice President

NEW YORK, NY -- (Marketwired) -- 12/18/14 -- Daxor Corp (NYSE MKT: DXR) announced today that it has appointed Michael Feldschuh as Executive Vice President, to head business development and strategic initiatives for Daxor Corporation as part of the firm's effort to build its medical device business. "We have exciting strategic goals for our medical device business, and Michael's appointment repr...

First Patients Examined with Ventripoint's Heart Analysis System in China at Shandong Provincial Hospital

SEATTLE, WASHINGTON -- (Marketwired) -- 12/18/14 -- Ventripoint Diagnostics Ltd. ("Ventripoint") (TSX VENTURE: VPT) is pleased to announce that it has installed its VMS™ heart analysis system at the Shandong Provincial Hospital (SPH) in Jinan, China and has examined a number of patients. The SPH does 300 cardiac ultrasound exams a day and has nine other hospitals in its group. "The cardiologis...

2015 Small-Cap Biotech Watchlist Announced

Release of The Life Sciences Report's 2015 Small-Cap Biotech Watchlist marks the third year we have brought together a team of analysts at the Biotech Showcase to compile a basket of stocks based on catalyst prospects for the coming year. This year's experts are some of the leading stock watchers in the space: Mara Goldstein, managing director and senior healthcare analyst at Cantor Fitzgerald; Re...

Trillium Therapeutics to List Common Shares on the NASDAQ Capital Market Under the Symbol TRIL

TORONTO, Dec. 18, 2014 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium") (TSX:TR) (OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that its common shares have been approved for listing on the NASDAQ Capital Market under the symbol "TRIL". Trading will commence on or around December 19. The Company will retain its list...

Ceapro Enters into Financing Agreement with Agriculture Financial Services Corporation

EDMONTON, ALBERTA -- (Marketwired) -- 12/18/14 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for health care and cosmetic industries, announced today that it has signed an Offer Letter with Agriculture Financial Services Corporation (AFSC) for a commercial financing of up t...

Parks Associates: 41% of U.S. Home Caregivers Use a Digital Health Device and 8% Use Online Tools to Coordinate Caregiving

DALLAS, TX -- (Marketwired) -- 12/18/14 -- Parks Associates finds 41% of caregivers in U.S. broadband households currently use a digital health device as part of their caregiving routine, including 8% who use online tools to coordinate their efforts. The research firm's 360 View: Health Devices and Services for Connected Consumers 2014 analyzes multiple consumer surveys, including a 2Q 2014 surve...

Capital Clinical Integrated Network (CCIN) and HEALTHEC First to Achieve EHNAC's Accountable Care Organization Accreditation

FARMINGTON, Conn., Dec. 18, 2014 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body for organizations that electronically exchange healthcare data, announced today that the first two organizations have achieved accreditation under its Accountable Care Organization programs. EHNAC offers two...

Machine Solutions Inc. Acquires Steeger USA

FLAGSTAFF, AZ -- (Marketwired) -- 12/18/14 -- Machine Solutions Inc. ("Machine Solutions") continues to grow its presence in the medical device manufacturing equipment market as evidenced by today's announcement that it has acquired Steeger USA. With headquarters in Spartanburg, South Carolina, Steeger USA is the leading manufacturer of braiding equipment for the medical device industry. Steeger...

Critical Outcome Technologies Inc. Extends Warrants Set to Expire December 20, 2014

LONDON, ONTARIO -- (Marketwired) -- 12/18/14 -- Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT)(OTCQB: COTQF), the biopharmaceutical company that uses machine learning to rapidly develop targeted therapies, announced today that it is amending the expiry date of 2,003,498 common share purchase warrants ("Warrants") issued as part of a non-brokered private placement...

Imperial Ginseng Products Ltd. Updates Voting Result on Amended and Restated Stock Option Plan

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/18/14 -- Imperial Ginseng Products Ltd. (TSX VENTURE: IGP)(TSX VENTURE: IGP.PRA.A) (the "Company" or "Imperial") announces that it has reverted to the previous stock option plan as the amended and restated stock option plan (the "New Plan") was not granted approval at the annual meeting. The New Plan was adopted by the Board of Directors on Octo...

Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 (c)(4)

Dicerna Pharmaceuticals, Inc. (“Dicerna” or the “Company”) (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Theodore (Ted) T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations. Dr. Ashburn brings 15 years of product and corporate development experience to Dicerna....

Critical Outcome Technologies Reports Fiscal 2015 Second Quarter Results / Highlighted by Development Milestones for COTI-2 as IND Filing Nears Completion

LONDON, ONTARIO -- (Marketwired) -- 12/17/14 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT)(OTCQB: COTQF) ("COTI" or the "Company") the biopharmaceutical company that uses machine learni...

XFRA CAPITAL ADJUSTMENT INFORMATION - 19.12.2014 - 1

FOLGENDE WERTPAPIERE WERDEN AM 18.12.2014 CUM KAPITALMASSNAHME UND AM 19.12.2014 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 18.12.2014 AND EX CAPITAL A...

XFRA CAPITAL ADJUSTMENT INFORMATION - 18.12.2014 - 2

FOLGENDE WERTPAPIERE WERDEN AM 18.12.2014 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 18.12.2014. INSTR EXCH ISIN INSTRUMENT NAME XFRA CA74071D1006 PRESC...

NHI Completes Acquisition of Eight Communities for $476 Million

National Health Investors, Inc. (NYSE:NHI) announced today it has closed the previously announced transaction to acquire eight senior housing communities for $476 million. All eight communities are leased to Senior Living Communities, LLC (“SLC”) and will continue to be managed by an SLC affiliate. The 15-year master lease equates to an initia...

Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable

Fitch Ratings has affirmed the ratings of Teva Pharmaceutical Industries Limited (Teva) and its subsidiaries at 'BBB+'. The Rating Outlook is Stable. A full list of rating actions, which apply to approximately $10.65 billion of debt at Sept. 30, 2014, follows at the end of this release. KEY RATING DRIVERS -- Teva is the wo...

Ebola centres overflow as Sierra Leone steps up fight

DEVIL HOLE, Sierra Leone (Reuters) - Ebola centres in Sierra Leone overflowed on Wednesday as health workers combed the streets of the capital Freetown for patients, after the government launched a major operation to contain the epidemic in West Afri...

Zoetis Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increase

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Tuesday, Mar. 3, 2015, to holders of record on Thursday, Jan. 22, 2015. “In 2014, we co...

Health Teams Scour Sierra Leone Capital in Drive to Contain Ebola

(Scientific American) – Health workers in Sierra Leone began combing the streets of the capital Freetown for Ebola patients on Wednesday, moving house-to-house as the government launched a major operation to contain infection in West AfricaR...

Ebola centers overflow as Sierra Leone steps up fight

DEVIL HOLE, Sierra Leone (Reuters) - Ebola centers in Sierra Leone overflowed on Wednesday as health workers combed the streets of the capital Freetown for patients, after the government launched a major operation to contain the epidemic in West Afri...

From American Well to Venture Capitalists, Health IT on the Rise

Companies in healthcare IT have been percolating for the past five-plus years. Now, with the regulatory climate evolving and big companies like Apple getting more serious about health and wellness, it looks like 2015 could be when it’s all going to...

Sorrento, NantWorks commit $20mm to new immunotherapies JV

Sorrento Therapeutics Inc. and NantWorks LLC founder Dr. Patrick Soon-Shiong have agreed to together invest $20mm in a new joint venture, to be named The Immunotherapy Antibody JV, which will operate as an independent entity.

Sapheneia / Scannerside Releases Revolutionary Lung Screening Software at Affordable Rates

Less than 30 days after the Sapheneia Scannerside partnership announcement, the two companies bring the first single-source solution for CMS Lung Screening, ClearCT™ Lung to market. On November 10, 2014, the U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening for Medicare recipients. Part of the radiology imag...

Coca-Cola-Aktie: schwacher Konsum von Erfrischungsgetränken mit Kohlesäure setzt sich fort! - Aktienanalyse

Toronto - Coca-Cola-Aktienanalyse von Analyst Amit Sharma von BMO Capital Markets: Amit Sharma, Aktienanalyst von BMO Capital Markets, bestätigt im Rahmen einer aktuellen Aktienanalyse hinsichtlich...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks